Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window
Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Becker, Stéphanie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time - Michaud, Jason E. ELSEVIER, 2023, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:42 ; year:2015 ; number:12 ; pages:923-930 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.nucmedbio.2015.08.002 |
|---|
| Katalog-ID: |
ELV029148987 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV029148987 | ||
| 003 | DE-627 | ||
| 005 | 20230623195614.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nucmedbio.2015.08.002 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015017000010.pica |
| 035 | |a (DE-627)ELV029148987 | ||
| 035 | |a (ELSEVIER)S0969-8051(15)00144-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 |a 570 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.88 |2 bkl | ||
| 100 | 1 | |a Becker, Stéphanie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| 264 | 1 | |c 2015 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. | ||
| 700 | 1 | |a Bohn, Pierre |4 oth | |
| 700 | 1 | |a Bouyeure-Petit, Anne-Charlotte |4 oth | |
| 700 | 1 | |a Modzelewski, Romain |4 oth | |
| 700 | 1 | |a Gensanne, David |4 oth | |
| 700 | 1 | |a Picquenot, Jean-Michel |4 oth | |
| 700 | 1 | |a Dubray, Bernard |4 oth | |
| 700 | 1 | |a Vera, Pierre |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Michaud, Jason E. ELSEVIER |t Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |d 2023 |g Amsterdam [u.a.] |w (DE-627)ELV010596976 |
| 773 | 1 | 8 | |g volume:42 |g year:2015 |g number:12 |g pages:923-930 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.nucmedbio.2015.08.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.88 |j Urologie |j Nephrologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 42 |j 2015 |e 12 |h 923-930 |g 8 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s b sb |
|---|---|
| matchkey_str |
beckerstphaniebohnpierrebouyeurepetitann:2015----:eaiuaehneefcecordohrpiaugdncrioaoetoerlovia |
| hierarchy_sort_str |
2015 |
| bklnumber |
44.88 |
| publishDate |
2015 |
| allfields |
10.1016/j.nucmedbio.2015.08.002 doi GBVA2015017000010.pica (DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Becker, Stéphanie verfasserin aut Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. Bohn, Pierre oth Bouyeure-Petit, Anne-Charlotte oth Modzelewski, Romain oth Gensanne, David oth Picquenot, Jean-Michel oth Dubray, Bernard oth Vera, Pierre oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:42 year:2015 number:12 pages:923-930 extent:8 https://doi.org/10.1016/j.nucmedbio.2015.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 42 2015 12 923-930 8 045F 610 |
| spelling |
10.1016/j.nucmedbio.2015.08.002 doi GBVA2015017000010.pica (DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Becker, Stéphanie verfasserin aut Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. Bohn, Pierre oth Bouyeure-Petit, Anne-Charlotte oth Modzelewski, Romain oth Gensanne, David oth Picquenot, Jean-Michel oth Dubray, Bernard oth Vera, Pierre oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:42 year:2015 number:12 pages:923-930 extent:8 https://doi.org/10.1016/j.nucmedbio.2015.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 42 2015 12 923-930 8 045F 610 |
| allfields_unstemmed |
10.1016/j.nucmedbio.2015.08.002 doi GBVA2015017000010.pica (DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Becker, Stéphanie verfasserin aut Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. Bohn, Pierre oth Bouyeure-Petit, Anne-Charlotte oth Modzelewski, Romain oth Gensanne, David oth Picquenot, Jean-Michel oth Dubray, Bernard oth Vera, Pierre oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:42 year:2015 number:12 pages:923-930 extent:8 https://doi.org/10.1016/j.nucmedbio.2015.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 42 2015 12 923-930 8 045F 610 |
| allfieldsGer |
10.1016/j.nucmedbio.2015.08.002 doi GBVA2015017000010.pica (DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Becker, Stéphanie verfasserin aut Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. Bohn, Pierre oth Bouyeure-Petit, Anne-Charlotte oth Modzelewski, Romain oth Gensanne, David oth Picquenot, Jean-Michel oth Dubray, Bernard oth Vera, Pierre oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:42 year:2015 number:12 pages:923-930 extent:8 https://doi.org/10.1016/j.nucmedbio.2015.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 42 2015 12 923-930 8 045F 610 |
| allfieldsSound |
10.1016/j.nucmedbio.2015.08.002 doi GBVA2015017000010.pica (DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Becker, Stéphanie verfasserin aut Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. Bohn, Pierre oth Bouyeure-Petit, Anne-Charlotte oth Modzelewski, Romain oth Gensanne, David oth Picquenot, Jean-Michel oth Dubray, Bernard oth Vera, Pierre oth Enthalten in Elsevier Science Michaud, Jason E. ELSEVIER Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time 2023 Amsterdam [u.a.] (DE-627)ELV010596976 volume:42 year:2015 number:12 pages:923-930 extent:8 https://doi.org/10.1016/j.nucmedbio.2015.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.88 Urologie Nephrologie VZ AR 42 2015 12 923-930 8 045F 610 |
| language |
English |
| source |
Enthalten in Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time Amsterdam [u.a.] volume:42 year:2015 number:12 pages:923-930 extent:8 |
| sourceStr |
Enthalten in Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time Amsterdam [u.a.] volume:42 year:2015 number:12 pages:923-930 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Urologie Nephrologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
| authorswithroles_txt_mv |
Becker, Stéphanie @@aut@@ Bohn, Pierre @@oth@@ Bouyeure-Petit, Anne-Charlotte @@oth@@ Modzelewski, Romain @@oth@@ Gensanne, David @@oth@@ Picquenot, Jean-Michel @@oth@@ Dubray, Bernard @@oth@@ Vera, Pierre @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV010596976 |
| dewey-sort |
3610 |
| id |
ELV029148987 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029148987</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195614.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nucmedbio.2015.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015017000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029148987</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-8051(15)00144-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.88</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becker, Stéphanie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bohn, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouyeure-Petit, Anne-Charlotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Modzelewski, Romain</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gensanne, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Picquenot, Jean-Michel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vera, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Michaud, Jason E. ELSEVIER</subfield><subfield code="t">Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time</subfield><subfield code="d">2023</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010596976</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:42</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:923-930</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nucmedbio.2015.08.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.88</subfield><subfield code="j">Urologie</subfield><subfield code="j">Nephrologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">42</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">923-930</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Becker, Stéphanie |
| spellingShingle |
Becker, Stéphanie ddc 610 ddc 570 bkl 44.88 Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| authorStr |
Becker, Stéphanie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV010596976 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| topic |
ddc 610 ddc 570 bkl 44.88 |
| topic_unstemmed |
ddc 610 ddc 570 bkl 44.88 |
| topic_browse |
ddc 610 ddc 570 bkl 44.88 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
p b pb a c b p acbp r m rm d g dg j m p jmp b d bd p v pv |
| hierarchy_parent_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
| hierarchy_parent_id |
ELV010596976 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV010596976 |
| title |
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| ctrlnum |
(DE-627)ELV029148987 (ELSEVIER)S0969-8051(15)00144-4 |
| title_full |
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| author_sort |
Becker, Stéphanie |
| journal |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
| journalStr |
Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
923 |
| author_browse |
Becker, Stéphanie |
| container_volume |
42 |
| physical |
8 |
| class |
610 570 610 DE-600 570 DE-600 610 VZ 44.88 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Becker, Stéphanie |
| doi_str_mv |
10.1016/j.nucmedbio.2015.08.002 |
| dewey-full |
610 570 |
| title_sort |
bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: role of αvβ3 imaging in determining optimal window |
| title_auth |
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| abstract |
Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. |
| abstractGer |
Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. |
| abstract_unstemmed |
Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
12 |
| title_short |
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window |
| url |
https://doi.org/10.1016/j.nucmedbio.2015.08.002 |
| remote_bool |
true |
| author2 |
Bohn, Pierre Bouyeure-Petit, Anne-Charlotte Modzelewski, Romain Gensanne, David Picquenot, Jean-Michel Dubray, Bernard Vera, Pierre |
| author2Str |
Bohn, Pierre Bouyeure-Petit, Anne-Charlotte Modzelewski, Romain Gensanne, David Picquenot, Jean-Michel Dubray, Bernard Vera, Pierre |
| ppnlink |
ELV010596976 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.nucmedbio.2015.08.002 |
| up_date |
2024-07-06T20:40:49.722Z |
| _version_ |
1803863667216744448 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029148987</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195614.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.nucmedbio.2015.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015017000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029148987</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0969-8051(15)00144-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.88</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Becker, Stéphanie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Earlier studies indicated that bevacizumab could favorably be combined with radiation. However excessive damage to tumor vasculature can result in radioresistance and clinical data suggest that treatment sequencing may be important when combining bevacizumab with radiation. The aim of this study was to evaluate whether αvβ3 scintigraphic imaging could provide information to determine the optimal combination schedule of bevacizumab and radiotherapy on a lung adenocarcinoma model in mice.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bohn, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouyeure-Petit, Anne-Charlotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Modzelewski, Romain</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gensanne, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Picquenot, Jean-Michel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vera, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Michaud, Jason E. ELSEVIER</subfield><subfield code="t">Inflammatory Expression Profiles in Bladder Exstrophy Smooth Muscle: Normalization Over Time</subfield><subfield code="d">2023</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010596976</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:42</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:923-930</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.nucmedbio.2015.08.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.88</subfield><subfield code="j">Urologie</subfield><subfield code="j">Nephrologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">42</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">923-930</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4030714 |